Nanion Corporate Blog


12.05.2017: New Application Note on TREK-1 is out!

The latest Application Note from Nanion shows recordings of TREK-1 on the SyncroPatch 384PE.

HEK cells expressing TREK-1 (an excellent cell line from SB Drug Discovery) were used on the SyncroPatch 384PE with a high success rate and BL-1249 and THA were used to activate and inhibit TREK-1, respectively. Read the full allpication note here.


Back to Overview

Contact Us

Please type your full name.
Invalid email address.
Invalid Input
Invalid Input
Nanion Technologies GmbH

Ganghoferstr. 70A
D-80339 Munich - Germany